XML 83 R66.htm IDEA: XBRL DOCUMENT v3.20.4
GOODWILL AND OTHER INTANGIBLE ASSETS (Narrative) (Details)
3 Months Ended 12 Months Ended
Sep. 30, 2020
USD ($)
Jun. 30, 2019
USD ($)
Dec. 31, 2020
USD ($)
reporting_unit
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Goodwill [Line Items]          
Number of reporting units | reporting_unit     3    
Impairment charge     $ 0 $ 5,764,000 $ 4,941,000
Amortization expense     74,500,000 72,800,000 71,600,000
Expected annual amortization expense, 2021     63,800,000    
Expected annual amortization expense, 2022     61,400,000    
Expected annual amortization expense, 2023     60,700,000    
Expected annual amortization expense, 2024     60,200,000    
Expected annual amortization expense, 2025     60,200,000    
Expected annual amortization expense, thereafter     512,300,000    
Amortization of product technology     $ 46,700,000 $ 45,800,000 $ 50,400,000
Codman          
Goodwill [Line Items]          
Impairment assessment, royalty rate 5.00%        
Impairment assessment, tax rate 24.00%        
Intangible assets, indefinite life, discount rate percentage 11.50%        
Intangible assets, indefinite lives, impairment $ 0        
Contract Manufacturing Customer, Notified By FDA To Remove Product From Market | Private Label | Customer Relationships          
Goodwill [Line Items]          
Impairment charge   $ 5,800,000